Please login to the form below

Lars Rebien Sørensen becomes chairman of Novo Holdings

He will take up the new role 1 July

Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.

He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.

“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.

Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.

30th May 2018

From: Sales

PME Digital Edition

Featured jobs

Account Director – UK Office: Excellent salary and benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Manager – Healthcare advertising: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...